Rapamune whistleblower suit sparks US House panel probe
This article was originally published in Scrip
Executive Summary
The US House Committee on Oversight and Government Reform has begun an investigation into claims that Wyeth(now a part of Pfizer) promoted the Rapamune (sirolimus) – a drug used in kidney transplants - for use in other unapproved organ transplant operations.